Cargando…
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
Dysregulated cholesterol metabolism is a hallmark of many cancers, including glioblastoma (GBM), but its role in disease progression is not well understood. Here, we identified cholesterol 24‐hydroxylase (CYP46A1), a brain‐specific enzyme responsible for the elimination of cholesterol through the co...
Autores principales: | Han, Mingzhi, Wang, Shuai, Yang, Ning, Wang, Xu, Zhao, Wenbo, Saed, Halala Sdik, Daubon, Thomas, Huang, Bin, Chen, Anjing, Li, Gang, Miletic, Hrvoje, Thorsen, Frits, Bjerkvig, Rolf, Li, Xingang, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949512/ https://www.ncbi.nlm.nih.gov/pubmed/31777202 http://dx.doi.org/10.15252/emmm.201910924 |
Ejemplares similares
-
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020) -
PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019) -
Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
por: Zhang, Xin, et al.
Publicado: (2017) -
Reduced expression of proteolipid protein 2 increases ER stress‐induced apoptosis and autophagy in glioblastoma
por: Feng, Zichao, et al.
Publicado: (2019) -
Targeting cholesterol homeostasis through inhibiting SREBP-2: An Achilles’ heel for glioblastoma
por: Sun, Yanfei, et al.
Publicado: (2023)